MultiOmic Health and Mesh Bio partner to use AI to develop precision medicines and diagnostics for chronic metabolic disease
MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, and Mesh Bio, a digital health startup transforming chronic disease management...